Legend BiotechLEGN
那斯達克 · USD
32.62
-1.58
(-4.62%)
收盤 06/06 03:59 (UTC+8)
盤後
32.87
+0.25
(+0.77%)
06/06 03:59 (UTC+8)
Legend BiotechLEGN
32.62
-1.58
(-4.62%)
財務數據
損益表
- 0.79
- 0.94
- 1.87
- 1.60
- 1.87
- 1.95
- 2.55
- 2.72
- 3.06
- 3.05
- -17.24
- 18.28
- 98.45
- -14.11
- 16.43
- 4.55
- 30.80
- 6.77
- 12.50
- -0.42
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 305,100 | 306,377 | 272,330 | 255,058 | 195,000 | 186,522 | 160,205 | 186,523 | 93,991 | 79,464 |
營業成本 | 175,900 | 123,459 | 115,306 | 97,991 | 71,300 | 73,922 | 55,469 | 50,451 | 54,739 | 32,450 |
營業毛利 | 129,200 | 182,918 | 157,024 | 157,067 | 123,700 | 112,600 | 104,736 | 136,072 | 39,252 | 47,014 |
營業費用 | 179,000 | 203,520 | 200,476 | 178,948 | 175,400 | 186,995 | 175,092 | 178,042 | 157,116 | 166,864 |
研發費用 | 85,700 | 101,326 | 113,148 | 98,302 | 101,900 | 104,432 | 95,522 | 112,626 | 100,964 | 105,683 |
推銷及管理費用 | 90,100 | 101,194 | 87,328 | 80,646 | 72,500 | 83,126 | 79,570 | 65,416 | 56,152 | 62,384 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 3,200 | - | - | - | 1,000 | -563 | -306 | -420 | -616 | -1,203 |
營業利益 | -49,800 | -20,602 | -43,452 | -21,881 | -51,700 | -74,395 | -70,356 | -41,970 | -117,864 | -119,850 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | 5,500 | 5,481 | 5,636 | 5,222 | 5,100 | 5,152 | 5,504 | 5,484 | 5,475 | 5,820 |
稅前純益 | -53,100 | -19,599 | -39,073 | -124,798 | -99,200 | 40,511 | -120,886 | -17,970 | -59,788 | -146,812 |
所得稅 | 1,200 | 11,216 | 616 | 582 | 1,800 | 14,227 | 4,435 | 226 | 5 | -1,994 |
稅後純益 | -54,300 | -30,815 | -39,689 | -125,380 | -101,000 | 26,284 | -125,321 | -18,196 | -59,793 | -144,818 |
基本每股稅後盈餘(元) | -0.30 | -0.16 | -0.22 | -0.68 | -0.54 | 0.14 | -0.68 | -0.10 | -0.32 | -0.80 |
稀釋每股稅後盈餘(元) | -0.30 | -0.16 | -0.22 | -0.68 | -0.54 | 0.14 | -0.68 | -0.10 | -0.32 | -0.80 |
基本平均股數(千股) | 185100.00 | 184733.00 | 184636.00 | 184135.00 | 183750.00 | 183324.00 | 183281.00 | 182602.00 | 182005.00 | 181827.00 |
稀釋平均股數(千股) | 185100.00 | 184733.00 | 184636.00 | 184135.00 | 183750.00 | 201403.00 | 183281.00 | 182602.00 | 182005.00 | 181827.00 |
還原基本每股稅後盈餘(元) | -0.30 | -0.16 | -0.22 | -0.68 | -0.54 | 0.14 | -0.68 | -0.10 | -0.32 | -0.80 |
還原稀釋每股稅後盈餘(元) | -0.30 | -0.16 | -0.22 | -0.68 | -0.54 | 0.14 | -0.68 | -0.10 | -0.32 | -0.80 |
還原基本平均股數(千股) | 185,100 | 184,733 | 184,636 | 184,135 | 183,750 | 183,324 | 183,281 | 182,602 | 182,005 | 181,827 |
還原稀釋平均股數(千股) | 185,100 | 184,733 | 184,636 | 184,135 | 183,750 | 201,403 | 183,281 | 182,602 | 182,005 | 181,827 |
EBITDA(千元) | -32,000 | -2,150 | -27,558 | -113,623 | -89,000 | 52,459 | -111,475 | -7,117 | -48,591 | -135,641 |